SC
About
Sangel Capital as one of the earliest globally operating professional biomedical venture capital institutions was established in China in 2010, focusing on life science and technology, and having leading professional advantages and rich project resources in the biomedical investment industry. Sangel Capital has offices in Shenzhen, Beijing, Suzhou, and Chicago. We bring together a group of investment and advisory teams composed of industry experts, scientists, and investors in the field of life technology to manage and operate a series of RMB and USD funds.
Position in the VCSift Database
- • 33,888 investors in VCSift focus on the fintech sector.
- • 615 investors are based in Shenzhen, Guangdong, China.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- fintech healthtech
- Location
- Shenzhen, China
Contact Information
linkedin.com/in/••••••••
Find more investors like Sangel
Search Investors